Real-Life Data, a Retrospective Report from Romania Hodgkin’s Lymphoma Registry – Single Center Experience

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Real-Life Data, a Retrospective Report from Romania Hodgkin’s Lymphoma Registry – Single Center Experience Oana Diana PREDA, Sorina BADELITA, Iulia URSULEAC, Razvan STOIA, Mariana VASILICA, Alexandru BARDAS, Ana-Manuela CRISAN, Sinziana BARBU, Andreea JERCAN,...

A Rare Case of Immunotactoid Glomerulopathy Associated with Monoclonal Gammopathy of Renal Significance and Potential Multiorgan Involvement

by Catalin | Mar 22, 2024 | 2024 vol. 2 Issue 1

A Rare Case of Immunotactoid Glomerulopathy Associated with Monoclonal Gammopathy of Renal Significance and Potential Multiorgan Involvement Larisa ZIDARU, Sorina BADELITA, Nicoleta PETRE, Daniel CORIU The term MGRS (Monoclonal Gammopathy of Renal Significance) is a...

Chronic Myeloid Leukemia Presenting with Megakaryocytic Blast Crisis: a Case Report with a Favorable Outcome

by Catalin | Mar 22, 2024 | 2024 vol. 2 Issue 1

Chronic Myeloid Leukemia Presenting with Megakaryocytic Blast Crisis: a Case Report with a Favorable Outcome Alexandra MARCOCI, Raluca Mihaela MANOLACHE, Radu Bogdan FLORESCU, Doina BARBU, Florentina GRADINARU, Silvana ANGELESCU, Andrei COLITA Chronic myeloid leukemia...

Multiple Myeloma and Solid Tumors – a Frequent Rarity –

by Catalin | Mar 22, 2024 | 2024 vol. 2 Issue 1

Multiple Myeloma and Solid Tumors – a Frequent Rarity – Loredana CIRLAN, Sorina BADELITA, Daniel CORIU Objective: Multiple Myeloma is defined by the proliferation of monoclonal B leukocytes (plasmacytes) in the bone marrow, which results in the production...

Checkpoint Inhibitors Prior to Autologous Stem Cell Transplantation for Relapsed/ Refractory Hodgkin Lymphoma

by Catalin | Mar 22, 2024 | 2024 vol. 2 Issue 1

Checkpoint Inhibitors Prior to Autologous Stem Cell Transplantation for Relapsed/ Refractory Hodgkin Lymphoma Elena NICORICI, Cosmin Daniel MINCIUNA, Catalin Doru DANAILA, Angela Smaranda DASCALESCU Aim: To present the evolution of our patients treated with checkpoint...